Xacduro
Generic name: sulbactam/durlobactam
Dosage form: Injection for intravenous infusion
Drug class: Penicillins / beta-lactamase inhibitors
What is Xacduro?
Xacduro is a combination antibiotic injection containing sulbactam and durlobactam that may be used in adults to treat hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.
Acinetobacter infections typically occur in healthcare settings, such as hospitals, with those on ventilators, with catheters, in ICU, with open surgical wounds, or with prolonged stays more at risk. Acinetobacter can spread through direct contact with contaminated surfaces or equipment or from person to person. They are responsible for over 8,500 infections a year in the U.S. and over 700 deaths and the World Health Organization has declared Acinetobacter species top of the list of critical bacterial pathogens that pose the greatest threat to human health. Most Acinetobacter infections are caused by one of four species from the Acinetobacter baumannii-calcoaceticus complex and are typically resistant to antibiotics, including carbapenem, making them difficult to treat.
Xacduro was approved on May 23, 2023.
Warnings
Xacduro should not be used in patients with a known hypersensitivity to sulbactam, other beta-lactam antibiotics, durlobactam, or any other components of the injection. If an allergic reaction occurs, discontinue Xacduro.
Xacduro may be associated with an increased risk of Clostridiodes difficile-associated diarrhea.
Should not be used to treat infections caused by pathogens other than Acinetobacter species.
Children
The safety and effectiveness of Xacduro in pediatric patients younger than 18 years of age has not been established.
Pregnancy
There are no specific data on the use of Xacduro during pregnancy.
Lactation
There are no data on the presence of durlobactam in human or animal milk. Sulbactam is present in human milk in low concentrations. There are no data on the effects of Xacduro, sulbactam, or durlobactam on the breastfed infant or on milk production.
How is Xacduro administered?
Xacduro is administered by intravenous infusion over three hours in people with CLCR of 45 mL/min to 129 mL/min. It is usually given every 6 hours. The prepared solution should be used immediately or stored in a refrigerator at 2°C to 8°C (36°F to 46°F) and used within 24 hours. Discard any unused portion not used within 24 hours.
A dosage reduction is needed in people with CLCR <45 mL/min, and an adjustment is needed for CLCR >130 mL/min.
What are the side effects of Xacduro?
The most common side effects of Xacduro from clinical trials were liver function test abnormalities, diarrhea, anemia, and hypokalemia (low potassium).
Related/similar drugs
Amoclan
Amoclan is used for aspiration pneumonia, bacterial infection, bronchiectasis, bronchitis, febrile ...
Augmentin
Augmentin is a prescription antibiotic combining amoxicillin and clavulanate to treat bacterial ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Augmentin XR
Augmentin XR is used for aspiration pneumonia, bacterial infection, bronchiectasis, bronchitis ...
Unasyn
Unasyn is used for aspiration pneumonia, bacterial infection, bone infection, deep neck infection ...
Zosyn
Zosyn is used to treat bacterial infections such as urinary tract and skin infections and ...
Piperacillin/tazobactam
Piperacillin/tazobactam systemic is used for appendectomy, appendicitis, aspiration pneumonia ...
Durlobactam/sulbactam
Durlobactam/sulbactam systemic is used for acinetobacter pneumonia
Ampicillin/sulbactam
Ampicillin/sulbactam systemic is used for aspiration pneumonia, bacterial infection, bone ...
Amoxicillin/clavulanate
Amoxicillin and clavulanate potassium is a combination antibiotic used to treat bacterial ...
What other drugs will affect Xacduro?
Plasma concentrations of Xacduro may be increased if given together with organic anion transporter 1 (OAT1) inhibitors, such as:
- cimetidine
- diclofenac
- probenecid.
Ingredients
Xacduro contains sulbactam, an antibiotic structurally related to penicillin that kills A. baumannii and durlobactam, a beta-lactamase inhibitor that prevents sulbactam from being degraded by beta-lactamase enzymes that may be produced by A. baumannii.
It is presented as a co-packaged kit that contains the following for reconstitution:
- 1 clear single-dose vial of sulbactam 1 gram
- 2 amber single-dose vials of durlobactam 0.5 gram.
Manufacturer
Entasis Therapeutics Ltd.
References
- Richard R Watkins , Robert A Bonomo, Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections, Clinical Infectious Diseases, Volume 76, Issue Supplement_2, 1 May 2023, Pages S163–S165
- Xacduro Prescribing Information
- FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
More about Xacduro (durlobactam / sulbactam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: penicillins/beta-lactamase inhibitors
- En español
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.